Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Provisional registration period extended to 30 April 2012
2012-03-25

25 March 2012

After a week of intense negotiations between the senior leadership of the University of the Free State (UFS) and the Student Representative Council (SRC) of the Bloemfontein and Qwaqwa Campuses, the SRC has managed to persuade the senior leadership to extend the provisional registration period to Monday 30 April 2012.

This means that, until 30 April 2012, no students will be deregistered for not being able to pay their provisional registration fee. The initial deadline for students to register provisionally was 6 April 2012.

The SRC requested the extension of provisional registration and the senior leadership of the UFS agreed thereto for the following reasons:

  • To allow students more time to raise the money;
  • To allow the provincial and national government, as well as NSFAS more time to respond to students’ financial needs; and
  • To allow the SRC and the university more time to consult with students with strong academic records about financial aid options outside the university.

“The SRC is glad to note that the university management values our efforts in representing our students and we've been able to leverage that advantage to negotiate an extension of the deregistration date with management. We're happy that in this case management has responded to the appeal of students through the SRC and we're exceptionally proud of our ability to push student interests to unprecedented heights,” says Mr Richard Chemaly, SRC President of the Bloemfontein Campus.

According to Mr Chemaly, the SRC is confident in their negotiation abilities. “While others might strike and protest, it is in the best interests of our students to talk to the senior leadership about important issues that are in the interests of students,” he says.

“Since our request to extend the provisional registration period was approved by the university management, the SRC has been working tirelessly to ensure that no deserving student gets deregistered. This includes setting up external funds, approaching the Premier’s office for assistance and setting up the most extensive bursary database any SRC has ever had,” Mr Chemaly says.

If there are any parents or students in need of help for provisional registration, please contact Mr Chemaly at  chemalyra@ufs.ac.za.
 

Media Release
25 March 2012
Issued by: Lacea Loader
Director: Strategic Communication
Tel: +27(0)51 401 2584
Cell: +27(0)83 645 2454
E-mail: news@ufs.ac.za

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept